Featured News Story
Breast Cancer Genetic Test Approved By FDA
A genetic test to determine whether a breast cancer patient is likely to respond to treatment with the drug Herceptin (trastuzumab) has been approved by the U.S. Food and Drug Administration.
Read MoreBreaking News
- Jul 8 2008 - 5:17pm
- Jul 8 2008 - 5:09pm
- Jul 8 2008 - 5:03pm
- Jul 8 2008 - 10:28am
- Jul 8 2008 - 10:28am
- Jul 8 2008 - 10:22am
- Jul 8 2008 - 10:20am
- Jul 8 2008 - 10:14am
- Jul 8 2008 - 10:08am
- Jul 8 2008 - 10:01am
- Jul 8 2008 - 6:26am
- Jul 8 2008 - 6:28am
- Jul 7 2008 - 5:23pm
